Clinical Trial Update: Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity

View source ↗

Summary

This completed AstraZeneca-sponsored trial evaluated a structured treatment approach for gastroesophageal reflux disease in a corporate health care setting and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: GERD | Status: COMPLETED